BTAL ETF: AGF U.S. Market Neutral Anti-Beta Fund - Price, Holdings & Analysis
AGF U.S. Market Neutral Anti-Beta Fund Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About AGF U.S. Market Neutral Anti-Beta Fund
What is the current price of BTAL?
The latest BTAL price is $11.84. The 52-week range is $10.86–$17.36. BTAL has returned -28.9% over the past 52 weeks.
What is the expense ratio for BTAL?
BTAL's annual expense ratio is 1.40%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Alternative ETFs in the ETF Screener.
Does BTAL pay dividends?
Yes, BTAL pays a 3.01% dividend yield. The last ex-dividend date was 2027-01-02. View full dividend history in the Dividends section.
What are the top holdings of BTAL?
BTAL's largest holdings are Murphy USA Inc (0.7%), Molina Healthcare, Inc (0.6%), F5 Networks, Inc (0.6%) (combined weight: 1.8%). The fund holds 405 total positions. View the complete portfolio breakdown in the Holdings section.
How does BTAL compare to similar ETFs?
Compare BTAL (1.40% expense ratio, $284M AUM) against similar Alternative ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.